FINNENCE▪
00:00:00 UTCSYS ONLINE
FINNENCE ▪ THE WIRE FILE

THE WIRE · № 72034

News■ Unclear/unknown

Par Health Issues Voluntary Nationwide Recall of Two Lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) Due to the Presence of Particulate Matter

EXHIBIT · mmx.prnewswire.com
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-08 22:00 UTC
LAST UPDATE2026-10-08 22:00 UTC
STATEactive

01 THE MACHINE READ

WHY IT MATTERS.

A single product recall has limited market impact absent revenue or supply-chain scale details.

Narrow recall with minimal investable relevance
CATALYST TO WATCH

Recall scope expansion or FDA action

MAIN RISK

Wider recall if contamination spreads

FULL DISPATCH

ROCHESTER, Mich., Oct. 8, 2026 /PRNewswire/ -- Par Health is voluntarily recalling two lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) to the hospital level. The product is being recalled due to the presence of particulate matter identified as cellulose....

02 THE STORY SO FAR

THE RECORD, IN ORDER.

STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.

03 WHO'S INVOLVED

ENTITIES ON FILE.

AFFECTEDHealthcare

04 RECEIPTS

THE SOURCE RECORD.

1 SOURCES CONFIRMED
№ 01prnewswireprnewswire.com · PRIMARY2026-10-08 22:00 UTCOPEN RECEIPT →

05 PROPAGATION

WHAT THIS TOUCHES.

←CORRELATIONshares Healthcare
Michigan Sues Blue Cross Blue Shield Over Alleged Antitrust Violations
2026-10-08 18:53 UTC
←CORRELATIONshares Healthcare
Brookdale Reports September 2026 Occupancy
2026-10-08 20:15 UTC
←CORRELATIONshares Healthcare
Small Biotech Catapults On $1.65 Billion Takeover Deal
2026-10-08 20:20 UTC

KEEP READING THE MACHINE

OPEN THE MACHINE →THE PREDICTION LEDGER →

Summaries are generated and may contain errors — every claim links its sources.